In the BioHarmony Drug Report Database
Cholic acid
Cholbam, Orphacol (cholic acid) is a small molecule pharmaceutical. Cholic acid was first approved as Cholbam on 2013-09-12. It is used to treat zellweger syndrome in the USA. It has been approved in Europe to treat digestive system diseases and inborn errors metabolism. It is known to target G-protein coupled bile acid receptor 1, bile acid receptor, and Putative regulatory protein.
Trade Name
|
Orphacol |
|---|---|
Common Name
|
cholic acid |
ChEMBL ID
|
CHEMBL205596 |
Indication
|
digestive system diseases, inborn errors metabolism, zellweger syndrome |
Drug Class
|
Image (chem structure or protein)